Pyxis Oncology, Inc.·4

Nov 17, 4:16 PM ET

Wadhane Jitendra 4

4 · Pyxis Oncology, Inc. · Filed Nov 17, 2023

Insider Transaction Report

Form 4
Period: 2023-11-15
Wadhane Jitendra
SVP, Chief Accounting Officer
Transactions
  • Award

    Common Stock

    2023-11-15+40,000266,937 total
Footnotes (1)
  • [F1]Represents restricted stock units that vest in full on November 14, 2024, subject to the Reporting Person's continued employment through the vesting date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION